Could Ozempic-Like Drugs Protect Bones While Helping…

Could Ozempic-Like Drugs Protect Bones While Helping Patients Lose Weight? Large Real-World Study Finds Lower Fracture Risk Among Semaglutide Users For years, clinicians have worried that significant weight loss could come with an unintended consequence: weaker bones. Weight reduction, particularly in older adults and people with chronic diseases, has often been associated with decreased bone density and a potentially higher risk of fractures. As newer weight-loss medications such as semaglutide have become increasingly popular, questions have emerged about their long-term effects on skeletal health. Now, new research presented at ENDO 2026 suggests the relationship may be more complex than previously thought. Researchers found that adults with type 2 diabetes taking semaglutide experienced fewer bone fractures than patients using several other commonly prescribed weight-loss medications, despite achieving greater reductions in body weight. Bone health is a major concern in people living with diabetes. Individuals with type 2 diabetes often face an elevated risk of fractures due to a combination of aging, metabolic changes, reduced mobility, and other health complications. At the same time, obesity itself places additional strain on joints and contributes to multiple chronic diseases. Weight loss can improve metabolic health, but rapid weight reduction has historically raised concerns about potential bone loss. This ha